跳转至内容
Merck
CN

HPLX1-115SP

MILLIPLEX® PLEXpedition Screening Panel

Configurable PLEXpedition Screening 115-Plex Panel

别名:

Human screening panel, Luminex human screening panel, Millipore screening kit, Human screening kit, Luminex human screening immunoassay, Millipore screening panel, Multiplex screening kit, Multiplex screening panel

登录 查看组织和合同定价。

关于此项目

NACRES:
NA.84
UNSPSC Code:
12161503
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

parameter

25 μL sample volume (per well)

assay range

intra-assay cv: ≤15, inter-assay cv: ≤20%
(≤25% for PDGF-AA)

technique(s)

multiplexing: suitable using : suitable

input

bronchoalveolar lavage
cell culture supernatant
cerebrospinal fluid(s) (CSF)
synovial fluid(s)
milk
serum
urine

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

The MILLIPLEX® PLEXpedition Screening Panel is a configurable multiplex immunoassay kit designed to simultaneously screen up to 115 targets, including cytokines, chemokines, and biomarkers related to bone health, metabolism, and cardiovascular disease. This discovery biomarker tool is offered in a matrix-free format for analyte detection across various sample types and serves as a bridge to to our commercially available Qualified assays for later-stage drug development and biomarker analysis.

Application

MILLIPLEX® Screening assays are fit-for-purpose toolsto enable the detection of biomarkers spanning mutiple research areas duringdiscovery and translational studies. Simultaneously analyze up to 115 analytesin mutiple human sample types including serum, plasma,cerebrospinal fluid(CSF), cell culture supernatants,brochoalveolar lavage (BAL), and milk.

Analytes included: The Luminex® xMAP® INTELLIFLEX and the FLEXMAP 3D® can detect all 115 analytes in this panel while the MAGPIX® and Luminex 200 instruments detect specific subsets of 50 and 80 analytes, respectively. It iscritical to know your type of instrument when selecting analytes. ▪MAGPIX®/Luminex 200/FLEXMAP 3D®/xMAP® INTELLIFLEX required for any orall of the following 50 analytes: EGF, FGF-2, Fractalkine, G-CSF,Ghrelin (Active), GIP, Glucagon, GM-CSF, Granzyme B, GROα, HGF, IFNα2, IFNγ,IL-1α, IL-1β, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40),IL-12 (p70), IL-13, IL-15, IL-17A, IL-18, IL-22, IL-23, IP-10, Leptin, MCP-1,MIG, MIP-1α, MIP-1β, OPN, PDGF-AA, PDGF-BB, Perforin, RANTES, sCD40L, SCF,sFAS, sFASL, TGFα, TNFα, TRAIL, VEGF-A.

Assay Characteristics: Refer to kit protocol for assay cross-reactivityand precision.

Features and Benefits

  • 115-Plex Capability: Screen up to 115 biomarkers simultaneously, streamlining your research and maximizing data output in a single assay run.
  • Sample Agnostic Design: Flexibility to analyze a wide variety of sample types, enhancing the applicability of your research across different biological contexts.
  • Belysa Software Integration: Utilize advanced curve fitting software to ensure reliable data analysis with every run.
  • Easy Transition to Qualified Assays: Seamlessly move from screening to qualified quantification with kits that share critical raw materials.
  • Comprehensive Analyte Coverage: Benefit from a broad selection of biomarkers relevant to inflammation, metabolism, cardiovascular health, and more.
  • Robust Technical Support: Access dedicated expert sales specialists and application scientists to assist with your biomarker needs.

Legal Information

FLEXMAP 3D is a registered trademark of Luminex Corp
Luminex is a registered trademark of Luminex Corp
Luminex 200 is a trademark of Luminex Corp
MAGPIX is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

存储类别

10 - Combustible liquids

wgk

WGK 3

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.

Simplify protein biomarker discovery with the MILLIPLEX® PLEXpedition 115-Plex Multiplex Screening Panel. Effortlessly screen cytokines and other markers with Luminex® technology.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持